Reference ranges and biological variation of free and total serum indoxyl- and p-cresyl sulphate measured with a rapid UPLC fluorescence detection method

Clinica Chimica Acta

Volumn 419, Issue , 2013, Pages 122-126

  Pretorius, Carel J ^a   McWhinney, Brett C ^a   Sipinkoski, Bilyana ^a   Johnson, Lambro A ^a   Rossi, Megan ^b,c   Campbell, Katrina L ^b,c   Ungerer, Jacobus P J ^a  

^a Pathology Queensland ^*  (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Biological variation; Chromatography; Haemodialysis; Reference range; Renal failure; Uremic toxin

Indexed keywords

4 CRESYLSULFATE; INDICAN; UNCLASSIFIED DRUG; UREMIC TOXIN;

ACCURACY; ANALYTIC METHOD; ARTICLE; FLUORESCENCE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; KIDNEY DYSFUNCTION; LIMIT OF DETECTION; NORMAL HUMAN; PRIORITY JOURNAL; REACTION TIME; REFERENCE VALUE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRESOLS; HUMANS; INDICAN; REFERENCE STANDARDS; REFERENCE VALUES; SPECTROMETRY, FLUORESCENCE; SULFURIC ACID ESTERS;

EID: 84875244795     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.02.008     Document Type: Article

References (21)

1. Meyer T.W., Hostetter T.H. Uremia. N Engl J Med 2007, 357:1316-1325.
2. Vanholder R., De Smet R., Glorieux G., et al. Review on uremic toxins: Classification, concentration and interindividual variability. Kidney Int 2003, 63:1934-1943.
3. Rossi M., Klein K., Johnson D.W., Campbell K.L. Pre-, pro- and symbiotics in uremic toxin development: a systematic review and meta-analysis (Review). Int J Nephrol 2012, 10.1155/2012/673631.
4. Patel K.P., Luo F.J., Plummer N.S., Hostetter T.H., Meyer T.W. The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores. Clin J Am Soc Nephrol 2012, 7:982-988.
5. Wu I., Hsu K., Hsu H., et al. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients - a prospective cohort study. Nephrol Dial Transplant 2012, 27:1169-1175.
6. Deguchi T., Ohtsuki S., Otagiri M., et al. Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. Kidney Int 2002, 61:1760-1768.
7. Miyamoto Y., Watanabe H., Noguchi T., et al. Organic anion transporters play an important role in the uptake of p-cresyl sulfate, a uremic toxin, in the kidney. Nephrol Dial Transplant 2011, 26:2498-2502.
8. Martinez A.W., Recht N.S., Hostetter T.H., Meyer T.W. Removal of p-cresol sulfate by hemodialysis. J Am Soc Nephrol 2005, 16:3430-3436.
9. Meijers B.K.I., De Loor H., Bammens B., Verbeke K., Vanrenterghem Y., Evenepoel P. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Clin J Am Soc Nephrol 2009, 4:1932-1938.
10. Krieter D.H., Hackl A., Rodriguez A., et al. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemofiltration. Nephrol Dial Transplant 2010, 25:212-215.
11. Lee C., Kuo C., Chen Y., et al. Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis. Perit Dial Int 2010, 30:456-463.
12. Calaf R., Cerini C., Genovesio C., et al. Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay. J Chromatogr B 2011, 879:2281-2286.
13. de Loor H., Meijers B.K.I., Meyer T.W., et al. Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence chromatography. J Chromatogr A 2009, 1216:4684-4688.
14. Liabeuf S., Barreto D.V., Barreto F.C., et al. Free p-cresyl sulfate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant 2010, 25:1183-1191.
15. Ragan M.A. Phenol sulfate esters: Ultraviolet, infrared, 1H and 13C nuclear magnetic resonance spectroscopic investigation. Can J Chem 1978, 56:2681-2685.
16. De Smet R., Van Kaer J., Liebich H., et al. Heparin-induced release of protein bound solutes during hemodialysis is an in vitro artefact. Clin Chem 2001, 47:901-909.
17. Clinical and Laboratory Standards Institute Defining, establishing, and verifying reference intervals in the clinical laboratory; Approved guideline 2008, CLSI document C28-A3 (ISBN 1-56238-628-4), CLSI, 940 West Valley Road, Suite 1400 Wayne, PA, 19087-1898 USA. 3rd ed.
18. Fraser G.G., Harris E.K. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989, 27:409-437.
19. Krebs M., Stingl H., Nowotny P., et al. Prevention of in vitro lipolysis by tetrahydrolipstatin. Clin Chem 2000, 46:950-954.
20. Wu I., Hsu K., Lee C., et al. p-Cresyl sulfate and indoxal sulfate predict progression of chronic kidney disease. Nephrol Dial Transplant 2011, 26:938-947.
21. Lin C., Chen H., Pan C., et al. p-Cresyl sulfate and indoxyl sulfate level at different stages of chronic kidney disease. J Clin Lab Anal 2011, 25:191-197.